Congenital Heart Disease is the first journal focusing on congenital heart disease in children and adults. Though the number of infants born with heart disease each year is relatively small (approximately 1% of the population), advances in treating such malformations have led to increased life spans for this population. Consequently, today most patients treated for congenital heart disease are over the age of 20. What are the special needs of adults with congenital heart disease? What are the latest developments in the care of the fetus, infants, and children? Who should treat these patients? How should they be treated?

Congenital Heart Disease focuses on these questions and more. Conceived as a forum for the most up-to-date information on congenital heart disease, the journal is led by Editor-in-Chief Vladimiro L. Vida, MD, Ph.D., Professor in Cardiac Surgery, University of Padua in Italy, as well as an international editorial board. We welcome submissions on congenital heart disease from the following areas:

• Basic research of congenital heart disease
• Clinical pediatric and adult cardiology
• Cardiac imaging
• Preventive cardiology
• Diagnostic and interventional cardiac catheterization
• Electrophysiology
• Surgery
• Long-term follow-up, particularly as it relates to older children and adult congenital heart disease
• Exercise and exercise physiology in the congenital patient
• Post-op and critical care
• Common disorders such as syncope, chest pain, murmurs, as well as acquired disorders such as Kawasaki syndrome

The journal includes clinical studies, invited editorials, state-of-the-art reviews, case reports, articles focusing on the history and development of congenital heart disease, and CME material. Occasional issues focus on special topics.

Official Journal of Children’s Hospital of Nanjing Medical University

Tech Science Press